A Study to Evaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus Patients
Condition: Type 2 Diabetes Mellitus Interventions: Drug: DBPR108; Placebo matching sitagliptin; Drug: Placebo matching DBPR108; Sitagliptin; DBPR108; Drug: Placebo matching DBPR108; Placebo matching sitagliptin; DBPR108 Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Januvia | Research | Study